Related Experiment Video

Updated: Jun 22, 2025

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
08:13

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

6.6K

Clinical pathway development to standardize pharmacological medication management of agitation in pediatric inpatient

Michael D Wood1,2, Kavi Gandhi2, Dean Elbe3,4,5

  • 1Faculty of Medicine, University of British Columbia (UBC); Vancouver, BC.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent
|July 2, 2024
PubMed

Insights

A new clinical pathway (CP) standardizes the pharmacological management of acute agitation in hospitalized children across Canada. This evidence-based guideline aims to improve patient care and provide a consistent approach for healthcare professionals.

Area of Science:

  • Pediatric hospital medicine
  • Clinical pharmacology
  • Healthcare guideline development

Background:

  • Acute agitation in pediatric patients is a common and challenging issue in hospitals.
  • Current management practices for pediatric agitation are highly variable.
  • Standardized pharmacologic guidelines are needed to ensure consistent and effective care.

Purpose of the Study:

  • To develop a novel clinical pathway (CP) for the management of acute agitation in all hospitalized pediatric patients in Canada.
  • To create a standardized approach to pharmacologic treatment for pediatric agitation.
  • To provide an accessible educational resource for healthcare professionals.

Main Methods:

  • A multidisciplinary working group of Canadian experts was formed.
  • A literature review and interdisciplinary consensus process were employed.
  • Feedback from internal and external partners guided revisions of the preliminary CP.

Main Results:

  • A pediatric inpatient CP was created, featuring a treatment algorithm and medication chart.
  • Supporting documents include non-pharmacologic strategies and an illustrative scenario.
  • The CP is designed as a user-friendly clinical and educational tool.

Conclusions:

  • This is the first CP to standardize pharmacologic management of acute agitation in hospitalized children in Canada.
  • The CP can be adapted by institutions to improve prompt management of pediatric agitation.
  • Further research is needed to evaluate implementation and support process improvement.
Abstract

Keywords:
adolescentagitationchemical restraintchildclinical pathwaypaediatricspediatricsyouth

More Related Videos

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

8.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.7K

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
41
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
565